PLAINSBORO, N.J., Dec. 13, 2007 (PRIME NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the launch of Integra(TM) Flowable Wound Matrix. Integra has received 510(k) clearance from the United States Food and Drug Administration to market Integra(TM) Flowable Wound Matrix in the United States.
